After celebrating the 20th anniversary of Emdogain® since it was launched on the market in 1995, Straumann is now setting new milestones in the area of oral tissue regeneration by extending the use of Emdogain® to improve soft tissue wound healing in oral surgical procedures and dental implantation procedures in general.
Straumann® Emdogain® is one of the best documented products in oral tissue regeneration. Its excellent clinical tolerability [1,2] has been demonstrated in over two million surgical applications. Emdogain® contains enamel matrix proteins (amelogenins). When applied to the wound, these proteins form an extracellular matrix that stimulates cells and processes that are fundamental for wound healing . These properties make Emdogain® a unique solution to stimulate and accelerate the healing of wounds and regeneration of tissues.
What leading experts say
Everybody who is creating a wound in the oral cavity, for instance in the context of conventional periodontal surgery, connective tissue harvesting, tooth extraction or even implant placement can use Emdogain® to improve early wound healing.
Emdogain® is a really unique protein mixture. It influences a number of different cells and a number of different processes. It really helps the wound healing and wound closure in the oral cavity.
New approved indication: the stimulation of soft tissue wound healing
Distinguish your practice by meeting your patients’ requirements. Adopt Emdogain® to achieve patient satisfaction.
Oral surgeries always bear the risk of undesired suffering of your patients such as pain and swelling of the soft tissues or wound healing complications –Emdogain® can increase your patients’ tolerance of surgical interventions by reducing these unwanted side effects.
The goal of every surgical procedure around teeth or dental implants is to restore the natural soft tissue architecture and esthetics for your patient –Emdogain® supports the soft tissue build-up and formation of keratinized gingiva necessary to achieve pleasing esthetic results.
Increase the quality of life for your patient by using Straumann® Emdogain®
- Informing the patient about possible undesired effects of the procedure
- Applying surgical techniques that reduce invasiveness
- Using additional products to improve healing; reduce pain, swelling, the risk of infections and wound complications.
Note: Straumann will launch the new application from April 2016, starting in Europe, with an official indication. The registration of this new indication in other countries outside Europe is currently ongoing. Since the product’s potential to stimulate wound healing is clearly documented, Straumann is committed to work with key opinion leaders and clinical experts to establish the new usage in key target indications, ranging from invasive to esthetic indications. Likewise, the combination of Emdogain® with existing products like the new Straumann® Bone Level Tapered Implant for esthetic and immediate indications, or with existing solutions like the Straumann® Pro Arch solution, will form the focus of our work to further improve these and other solutions for the benefit of our clinicians and patients.
Article no. 157
Facebook: Straumann UK